NCT07700472
- Conditions
- Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +10 more
- Locations
-
- The First Affiliated Hospital of Chongqing Medical University Chongqing, Choongqing, China
Clinical trial condition
Adrenal Cortex Diseases
Explore clinical trials studying Adrenal Cortex Diseases. Study availability and eligibility vary by location and protocol.
98 public trials
28 recruiting studies
Adrenal Cortex Diseases trial results
Not yet recruiting
A Prospective, Randomized, Multicenter Clinical Study Comparing Adjuvant Radiotherapy Versus Observation in High-risk Localized Adrenocortical Carcinoma After Surgery.
NCT07141147
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +12 more
- Locations
-
- Cancer Center, Sun Yat-sen University Guangzhou, Guangdong, China
Enrolling by invitation
A Prospective Cohort Study for Patients With Adrenal Diseases
NCT03474237
- Conditions
- ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Adenoma, +26 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Active, not recruiting
Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
NCT02867592
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +92 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- Providence Alaska Medical Center Anchorage, Alaska, United States
- Arkansas Children's Hospital Little Rock, Arkansas, United States
- Kaiser Permanente-Anaheim Anaheim, California, United States
Active, not recruiting
Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome
NCT03604198
- Conditions
- ACTH Syndrome, Ectopic, Adenocarcinoma, Adrenal Cortex Diseases, +30 more
- Locations
-
- Site 49 Phoenix, Arizona, United States
- Site 35 Stanford, California, United States
- Site 39 Torrance, California, United States
- Site 50 Miami, Florida, United States
Active, not recruiting
Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors
NCT03333616
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +28 more
- Locations
-
- University of California, San Diego Moores Cancer Center La Jolla, California, United States
- Winship Cancer Institute, Emory University Atlanta, Georgia, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
Active, not recruiting
Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic
NCT02721732
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +59 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
NCT02834013
- Conditions
- Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
Active, not recruiting
Preclinical Study Towards an Immunotherapy in Adrenocortical Carcinoma
NCT00457587
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +13 more
- Locations
-
- Dept. of Medicine I, University of Wuerzburg Würzburg, Germany
Active, not recruiting
Evaluation of Side Effects of Mitotane
NCT00568139
- Conditions
- Adenocarcinoma, Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, +10 more
- Locations
-
- University Hospital Würzburg, Germany